Global RSV mRNA Vaccine Market Research Report 2026(Status and Outlook)
RSV mRNA Vaccine is an mRNA vaccine targeting Respiratory Syncytial Virus (RSV). RSV is a common respiratory virus that can cause cold-like symptoms and lower respiratory tract infections, particularly in infants, toddlers, and older adults. The RSV mRNA Vaccine utilizes mRNA technology to introduce mRNA sequences encoding RSV virus antigens into human cells, thereby inducing an immune response against RSV. This vaccine offers advantages such as high efficiency, safety, and ease of production, providing a new solution for preventing RSV infections. By administering the RSV mRNA Vaccine, the risk of RSV infection can be effectively reduced, related symptoms can be alleviated, and complications caused by RSV infections can be decreased.
The global RSV mRNA Vaccine market size was estimated at USD 536.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global RSV mRNA Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global RSV mRNA Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the RSV mRNA Vaccine market.
Global RSV mRNA Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abogen Bio
Innorna
Starna Therapeutics
Hualan Biological Engineering
SINOVAC
Moderna
GSK
Pfizer
Sanofi
Nanoribo
Immorna
AIM Vaccine
Shijiazhuang Pharma Group
Market Segmentation (by Type)
Base Modification Technology
m1? Modification Technology
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RSV mRNA Vaccine Market
Overview of the regional outlook of the RSV mRNA Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RSV mRNA Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of RSV mRNA Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global RSV mRNA Vaccine market size was estimated at USD 536.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global RSV mRNA Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global RSV mRNA Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the RSV mRNA Vaccine market.
Global RSV mRNA Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abogen Bio
Innorna
Starna Therapeutics
Hualan Biological Engineering
SINOVAC
Moderna
GSK
Pfizer
Sanofi
Nanoribo
Immorna
AIM Vaccine
Shijiazhuang Pharma Group
Market Segmentation (by Type)
Base Modification Technology
m1? Modification Technology
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RSV mRNA Vaccine Market
Overview of the regional outlook of the RSV mRNA Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RSV mRNA Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of RSV mRNA Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of RSV mRNA Vaccine
1.2 Key Market Segments
1.2.1 RSV mRNA Vaccine Segment by Type
1.2.2 RSV mRNA Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RSV MRNA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RSV mRNA Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global RSV mRNA Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RSV MRNA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global RSV mRNA Vaccine Product Life Cycle
3.3 Global RSV mRNA Vaccine Sales by Manufacturers (2020-2025)
3.4 Global RSV mRNA Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 RSV mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global RSV mRNA Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 RSV mRNA Vaccine Market Competitive Situation and Trends
3.8.1 RSV mRNA Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest RSV mRNA Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RSV MRNA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 RSV mRNA Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RSV MRNA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global RSV mRNA Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to RSV mRNA Vaccine Market
5.7 ESG Ratings of Leading Companies
6 RSV MRNA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
6.3 Global RSV mRNA Vaccine Market Size by Type (2020-2025)
6.4 Global RSV mRNA Vaccine Price by Type (2020-2025)
7 RSV MRNA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RSV mRNA Vaccine Market Sales by Application (2020-2025)
7.3 Global RSV mRNA Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
8 RSV MRNA VACCINE MARKET SALES BY REGION
8.1 Global RSV mRNA Vaccine Sales by Region
8.1.1 Global RSV mRNA Vaccine Sales by Region
8.1.2 Global RSV mRNA Vaccine Sales Market Share by Region
8.2 Global RSV mRNA Vaccine Market Size by Region
8.2.1 Global RSV mRNA Vaccine Market Size by Region
8.2.2 Global RSV mRNA Vaccine Market Size by Region
8.3 North America
8.3.1 North America RSV mRNA Vaccine Sales by Country
8.3.2 North America RSV mRNA Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe RSV mRNA Vaccine Sales by Country
8.4.2 Europe RSV mRNA Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific RSV mRNA Vaccine Sales by Region
8.5.2 Asia Pacific RSV mRNA Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America RSV mRNA Vaccine Sales by Country
8.6.2 South America RSV mRNA Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa RSV mRNA Vaccine Sales by Region
8.7.2 Middle East and Africa RSV mRNA Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RSV MRNA VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of RSV mRNA Vaccine by Region(2020-2025)
9.2 Global RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America RSV mRNA Vaccine Production
9.4.1 North America RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.4.2 North America RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe RSV mRNA Vaccine Production
9.5.1 Europe RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan RSV mRNA Vaccine Production (2020-2025)
9.6.1 Japan RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China RSV mRNA Vaccine Production (2020-2025)
9.7.1 China RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.7.2 China RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abogen Bio
10.1.1 Abogen Bio Basic Information
10.1.2 Abogen Bio RSV mRNA Vaccine Product Overview
10.1.3 Abogen Bio RSV mRNA Vaccine Product Market Performance
10.1.4 Abogen Bio Business Overview
10.1.5 Abogen Bio SWOT Analysis
10.1.6 Abogen Bio Recent Developments
10.2 Innorna
10.2.1 Innorna Basic Information
10.2.2 Innorna RSV mRNA Vaccine Product Overview
10.2.3 Innorna RSV mRNA Vaccine Product Market Performance
10.2.4 Innorna Business Overview
10.2.5 Innorna SWOT Analysis
10.2.6 Innorna Recent Developments
10.3 Starna Therapeutics
10.3.1 Starna Therapeutics Basic Information
10.3.2 Starna Therapeutics RSV mRNA Vaccine Product Overview
10.3.3 Starna Therapeutics RSV mRNA Vaccine Product Market Performance
10.3.4 Starna Therapeutics Business Overview
10.3.5 Starna Therapeutics SWOT Analysis
10.3.6 Starna Therapeutics Recent Developments
10.4 Hualan Biological Engineering
10.4.1 Hualan Biological Engineering Basic Information
10.4.2 Hualan Biological Engineering RSV mRNA Vaccine Product Overview
10.4.3 Hualan Biological Engineering RSV mRNA Vaccine Product Market Performance
10.4.4 Hualan Biological Engineering Business Overview
10.4.5 Hualan Biological Engineering Recent Developments
10.5 SINOVAC
10.5.1 SINOVAC Basic Information
10.5.2 SINOVAC RSV mRNA Vaccine Product Overview
10.5.3 SINOVAC RSV mRNA Vaccine Product Market Performance
10.5.4 SINOVAC Business Overview
10.5.5 SINOVAC Recent Developments
10.6 Moderna
10.6.1 Moderna Basic Information
10.6.2 Moderna RSV mRNA Vaccine Product Overview
10.6.3 Moderna RSV mRNA Vaccine Product Market Performance
10.6.4 Moderna Business Overview
10.6.5 Moderna Recent Developments
10.7 GSK
10.7.1 GSK Basic Information
10.7.2 GSK RSV mRNA Vaccine Product Overview
10.7.3 GSK RSV mRNA Vaccine Product Market Performance
10.7.4 GSK Business Overview
10.7.5 GSK Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer RSV mRNA Vaccine Product Overview
10.8.3 Pfizer RSV mRNA Vaccine Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Sanofi
10.9.1 Sanofi Basic Information
10.9.2 Sanofi RSV mRNA Vaccine Product Overview
10.9.3 Sanofi RSV mRNA Vaccine Product Market Performance
10.9.4 Sanofi Business Overview
10.9.5 Sanofi Recent Developments
10.10 Nanoribo
10.10.1 Nanoribo Basic Information
10.10.2 Nanoribo RSV mRNA Vaccine Product Overview
10.10.3 Nanoribo RSV mRNA Vaccine Product Market Performance
10.10.4 Nanoribo Business Overview
10.10.5 Nanoribo Recent Developments
10.11 Immorna
10.11.1 Immorna Basic Information
10.11.2 Immorna RSV mRNA Vaccine Product Overview
10.11.3 Immorna RSV mRNA Vaccine Product Market Performance
10.11.4 Immorna Business Overview
10.11.5 Immorna Recent Developments
10.12 AIM Vaccine
10.12.1 AIM Vaccine Basic Information
10.12.2 AIM Vaccine RSV mRNA Vaccine Product Overview
10.12.3 AIM Vaccine RSV mRNA Vaccine Product Market Performance
10.12.4 AIM Vaccine Business Overview
10.12.5 AIM Vaccine Recent Developments
10.13 Shijiazhuang Pharma Group
10.13.1 Shijiazhuang Pharma Group Basic Information
10.13.2 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Overview
10.13.3 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Market Performance
10.13.4 Shijiazhuang Pharma Group Business Overview
10.13.5 Shijiazhuang Pharma Group Recent Developments
11 RSV MRNA VACCINE MARKET FORECAST BY REGION
11.1 Global RSV mRNA Vaccine Market Size Forecast
11.2 Global RSV mRNA Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe RSV mRNA Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific RSV mRNA Vaccine Market Size Forecast by Region
11.2.4 South America RSV mRNA Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of RSV mRNA Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global RSV mRNA Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of RSV mRNA Vaccine by Type (2026-2035)
12.1.2 Global RSV mRNA Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of RSV mRNA Vaccine by Type (2026-2035)
12.2 Global RSV mRNA Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global RSV mRNA Vaccine Sales (K MT) Forecast by Application
12.2.2 Global RSV mRNA Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of RSV mRNA Vaccine
1.2 Key Market Segments
1.2.1 RSV mRNA Vaccine Segment by Type
1.2.2 RSV mRNA Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RSV MRNA VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global RSV mRNA Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global RSV mRNA Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RSV MRNA VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global RSV mRNA Vaccine Product Life Cycle
3.3 Global RSV mRNA Vaccine Sales by Manufacturers (2020-2025)
3.4 Global RSV mRNA Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 RSV mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global RSV mRNA Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 RSV mRNA Vaccine Market Competitive Situation and Trends
3.8.1 RSV mRNA Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest RSV mRNA Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RSV MRNA VACCINE INDUSTRY CHAIN ANALYSIS
4.1 RSV mRNA Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RSV MRNA VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global RSV mRNA Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to RSV mRNA Vaccine Market
5.7 ESG Ratings of Leading Companies
6 RSV MRNA VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
6.3 Global RSV mRNA Vaccine Market Size by Type (2020-2025)
6.4 Global RSV mRNA Vaccine Price by Type (2020-2025)
7 RSV MRNA VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RSV mRNA Vaccine Market Sales by Application (2020-2025)
7.3 Global RSV mRNA Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
8 RSV MRNA VACCINE MARKET SALES BY REGION
8.1 Global RSV mRNA Vaccine Sales by Region
8.1.1 Global RSV mRNA Vaccine Sales by Region
8.1.2 Global RSV mRNA Vaccine Sales Market Share by Region
8.2 Global RSV mRNA Vaccine Market Size by Region
8.2.1 Global RSV mRNA Vaccine Market Size by Region
8.2.2 Global RSV mRNA Vaccine Market Size by Region
8.3 North America
8.3.1 North America RSV mRNA Vaccine Sales by Country
8.3.2 North America RSV mRNA Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe RSV mRNA Vaccine Sales by Country
8.4.2 Europe RSV mRNA Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific RSV mRNA Vaccine Sales by Region
8.5.2 Asia Pacific RSV mRNA Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America RSV mRNA Vaccine Sales by Country
8.6.2 South America RSV mRNA Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa RSV mRNA Vaccine Sales by Region
8.7.2 Middle East and Africa RSV mRNA Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RSV MRNA VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of RSV mRNA Vaccine by Region(2020-2025)
9.2 Global RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America RSV mRNA Vaccine Production
9.4.1 North America RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.4.2 North America RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe RSV mRNA Vaccine Production
9.5.1 Europe RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan RSV mRNA Vaccine Production (2020-2025)
9.6.1 Japan RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China RSV mRNA Vaccine Production (2020-2025)
9.7.1 China RSV mRNA Vaccine Production Growth Rate (2020-2025)
9.7.2 China RSV mRNA Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abogen Bio
10.1.1 Abogen Bio Basic Information
10.1.2 Abogen Bio RSV mRNA Vaccine Product Overview
10.1.3 Abogen Bio RSV mRNA Vaccine Product Market Performance
10.1.4 Abogen Bio Business Overview
10.1.5 Abogen Bio SWOT Analysis
10.1.6 Abogen Bio Recent Developments
10.2 Innorna
10.2.1 Innorna Basic Information
10.2.2 Innorna RSV mRNA Vaccine Product Overview
10.2.3 Innorna RSV mRNA Vaccine Product Market Performance
10.2.4 Innorna Business Overview
10.2.5 Innorna SWOT Analysis
10.2.6 Innorna Recent Developments
10.3 Starna Therapeutics
10.3.1 Starna Therapeutics Basic Information
10.3.2 Starna Therapeutics RSV mRNA Vaccine Product Overview
10.3.3 Starna Therapeutics RSV mRNA Vaccine Product Market Performance
10.3.4 Starna Therapeutics Business Overview
10.3.5 Starna Therapeutics SWOT Analysis
10.3.6 Starna Therapeutics Recent Developments
10.4 Hualan Biological Engineering
10.4.1 Hualan Biological Engineering Basic Information
10.4.2 Hualan Biological Engineering RSV mRNA Vaccine Product Overview
10.4.3 Hualan Biological Engineering RSV mRNA Vaccine Product Market Performance
10.4.4 Hualan Biological Engineering Business Overview
10.4.5 Hualan Biological Engineering Recent Developments
10.5 SINOVAC
10.5.1 SINOVAC Basic Information
10.5.2 SINOVAC RSV mRNA Vaccine Product Overview
10.5.3 SINOVAC RSV mRNA Vaccine Product Market Performance
10.5.4 SINOVAC Business Overview
10.5.5 SINOVAC Recent Developments
10.6 Moderna
10.6.1 Moderna Basic Information
10.6.2 Moderna RSV mRNA Vaccine Product Overview
10.6.3 Moderna RSV mRNA Vaccine Product Market Performance
10.6.4 Moderna Business Overview
10.6.5 Moderna Recent Developments
10.7 GSK
10.7.1 GSK Basic Information
10.7.2 GSK RSV mRNA Vaccine Product Overview
10.7.3 GSK RSV mRNA Vaccine Product Market Performance
10.7.4 GSK Business Overview
10.7.5 GSK Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer RSV mRNA Vaccine Product Overview
10.8.3 Pfizer RSV mRNA Vaccine Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Sanofi
10.9.1 Sanofi Basic Information
10.9.2 Sanofi RSV mRNA Vaccine Product Overview
10.9.3 Sanofi RSV mRNA Vaccine Product Market Performance
10.9.4 Sanofi Business Overview
10.9.5 Sanofi Recent Developments
10.10 Nanoribo
10.10.1 Nanoribo Basic Information
10.10.2 Nanoribo RSV mRNA Vaccine Product Overview
10.10.3 Nanoribo RSV mRNA Vaccine Product Market Performance
10.10.4 Nanoribo Business Overview
10.10.5 Nanoribo Recent Developments
10.11 Immorna
10.11.1 Immorna Basic Information
10.11.2 Immorna RSV mRNA Vaccine Product Overview
10.11.3 Immorna RSV mRNA Vaccine Product Market Performance
10.11.4 Immorna Business Overview
10.11.5 Immorna Recent Developments
10.12 AIM Vaccine
10.12.1 AIM Vaccine Basic Information
10.12.2 AIM Vaccine RSV mRNA Vaccine Product Overview
10.12.3 AIM Vaccine RSV mRNA Vaccine Product Market Performance
10.12.4 AIM Vaccine Business Overview
10.12.5 AIM Vaccine Recent Developments
10.13 Shijiazhuang Pharma Group
10.13.1 Shijiazhuang Pharma Group Basic Information
10.13.2 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Overview
10.13.3 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Market Performance
10.13.4 Shijiazhuang Pharma Group Business Overview
10.13.5 Shijiazhuang Pharma Group Recent Developments
11 RSV MRNA VACCINE MARKET FORECAST BY REGION
11.1 Global RSV mRNA Vaccine Market Size Forecast
11.2 Global RSV mRNA Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe RSV mRNA Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific RSV mRNA Vaccine Market Size Forecast by Region
11.2.4 South America RSV mRNA Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of RSV mRNA Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global RSV mRNA Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of RSV mRNA Vaccine by Type (2026-2035)
12.1.2 Global RSV mRNA Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of RSV mRNA Vaccine by Type (2026-2035)
12.2 Global RSV mRNA Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global RSV mRNA Vaccine Sales (K MT) Forecast by Application
12.2.2 Global RSV mRNA Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global RSV mRNA Vaccine Market Size by Type (M USD)
Table 4. Global RSV mRNA Vaccine Market Size by Application
Table 5. RSV mRNA Vaccine Market Size Comparison by Region (M USD)
Table 6. Global RSV mRNA Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global RSV mRNA Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global RSV mRNA Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global RSV mRNA Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV mRNA Vaccine as of 2025)
Table 11. Global Market RSV mRNA Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global RSV mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RSV mRNA Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global RSV mRNA Vaccine Sales by Type (K MT)
Table 27. Global RSV mRNA Vaccine Market Size by Type (M USD)
Table 28. Global RSV mRNA Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global RSV mRNA Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global RSV mRNA Vaccine Market Share by Type (2020-2025)
Table 32. Global RSV mRNA Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global RSV mRNA Vaccine Sales (K MT) by Application
Table 34. Global RSV mRNA Vaccine Market Size by Application
Table 35. Global RSV mRNA Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global RSV mRNA Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global RSV mRNA Vaccine Market Share by Application (2020-2025)
Table 39. Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global RSV mRNA Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global RSV mRNA Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global RSV mRNA Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global RSV mRNA Vaccine Market Size by Region (2020-2025)
Table 44. North America RSV mRNA Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America RSV mRNA Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe RSV mRNA Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe RSV mRNA Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific RSV mRNA Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific RSV mRNA Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America RSV mRNA Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America RSV mRNA Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa RSV mRNA Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa RSV mRNA Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global RSV mRNA Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global RSV mRNA Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Abogen Bio Basic Information
Table 63. Abogen Bio RSV mRNA Vaccine Product Overview
Table 64. Abogen Bio RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Abogen Bio Business Overview
Table 66. Abogen Bio SWOT Analysis
Table 67. Abogen Bio Recent Developments
Table 68. Innorna Basic Information
Table 69. Innorna RSV mRNA Vaccine Product Overview
Table 70. Innorna RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Innorna Business Overview
Table 72. Innorna SWOT Analysis
Table 73. Innorna Recent Developments
Table 74. Starna Therapeutics Basic Information
Table 75. Starna Therapeutics RSV mRNA Vaccine Product Overview
Table 76. Starna Therapeutics RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Starna Therapeutics Business Overview
Table 78. Starna Therapeutics SWOT Analysis
Table 79. Starna Therapeutics Recent Developments
Table 80. Hualan Biological Engineering Basic Information
Table 81. Hualan Biological Engineering RSV mRNA Vaccine Product Overview
Table 82. Hualan Biological Engineering RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Hualan Biological Engineering Business Overview
Table 84. Hualan Biological Engineering Recent Developments
Table 85. SINOVAC Basic Information
Table 86. SINOVAC RSV mRNA Vaccine Product Overview
Table 87. SINOVAC RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. SINOVAC Business Overview
Table 89. SINOVAC Recent Developments
Table 90. Moderna Basic Information
Table 91. Moderna RSV mRNA Vaccine Product Overview
Table 92. Moderna RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Moderna Business Overview
Table 94. Moderna Recent Developments
Table 95. GSK Basic Information
Table 96. GSK RSV mRNA Vaccine Product Overview
Table 97. GSK RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GSK Business Overview
Table 99. GSK Recent Developments
Table 100. Pfizer Basic Information
Table 101. Pfizer RSV mRNA Vaccine Product Overview
Table 102. Pfizer RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Pfizer Business Overview
Table 104. Pfizer Recent Developments
Table 105. Sanofi Basic Information
Table 106. Sanofi RSV mRNA Vaccine Product Overview
Table 107. Sanofi RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sanofi Business Overview
Table 109. Sanofi Recent Developments
Table 110. Nanoribo Basic Information
Table 111. Nanoribo RSV mRNA Vaccine Product Overview
Table 112. Nanoribo RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Nanoribo Business Overview
Table 114. Nanoribo Recent Developments
Table 115. Immorna Basic Information
Table 116. Immorna RSV mRNA Vaccine Product Overview
Table 117. Immorna RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Immorna Business Overview
Table 119. Immorna Recent Developments
Table 120. AIM Vaccine Basic Information
Table 121. AIM Vaccine RSV mRNA Vaccine Product Overview
Table 122. AIM Vaccine RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. AIM Vaccine Business Overview
Table 124. AIM Vaccine Recent Developments
Table 125. Shijiazhuang Pharma Group Basic Information
Table 126. Shijiazhuang Pharma Group RSV mRNA Vaccine Product Overview
Table 127. Shijiazhuang Pharma Group RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shijiazhuang Pharma Group Business Overview
Table 129. Shijiazhuang Pharma Group Recent Developments
Table 130. Global RSV mRNA Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global RSV mRNA Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific RSV mRNA Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific RSV mRNA Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global RSV mRNA Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global RSV mRNA Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global RSV mRNA Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global RSV mRNA Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global RSV mRNA Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global RSV mRNA Vaccine Market Size by Type (M USD)
Table 4. Global RSV mRNA Vaccine Market Size by Application
Table 5. RSV mRNA Vaccine Market Size Comparison by Region (M USD)
Table 6. Global RSV mRNA Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global RSV mRNA Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global RSV mRNA Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global RSV mRNA Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV mRNA Vaccine as of 2025)
Table 11. Global Market RSV mRNA Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global RSV mRNA Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RSV mRNA Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global RSV mRNA Vaccine Sales by Type (K MT)
Table 27. Global RSV mRNA Vaccine Market Size by Type (M USD)
Table 28. Global RSV mRNA Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global RSV mRNA Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global RSV mRNA Vaccine Market Share by Type (2020-2025)
Table 32. Global RSV mRNA Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global RSV mRNA Vaccine Sales (K MT) by Application
Table 34. Global RSV mRNA Vaccine Market Size by Application
Table 35. Global RSV mRNA Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global RSV mRNA Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global RSV mRNA Vaccine Market Share by Application (2020-2025)
Table 39. Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global RSV mRNA Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global RSV mRNA Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global RSV mRNA Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global RSV mRNA Vaccine Market Size by Region (2020-2025)
Table 44. North America RSV mRNA Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America RSV mRNA Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe RSV mRNA Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe RSV mRNA Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific RSV mRNA Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific RSV mRNA Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America RSV mRNA Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America RSV mRNA Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa RSV mRNA Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa RSV mRNA Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global RSV mRNA Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global RSV mRNA Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China RSV mRNA Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Abogen Bio Basic Information
Table 63. Abogen Bio RSV mRNA Vaccine Product Overview
Table 64. Abogen Bio RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Abogen Bio Business Overview
Table 66. Abogen Bio SWOT Analysis
Table 67. Abogen Bio Recent Developments
Table 68. Innorna Basic Information
Table 69. Innorna RSV mRNA Vaccine Product Overview
Table 70. Innorna RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Innorna Business Overview
Table 72. Innorna SWOT Analysis
Table 73. Innorna Recent Developments
Table 74. Starna Therapeutics Basic Information
Table 75. Starna Therapeutics RSV mRNA Vaccine Product Overview
Table 76. Starna Therapeutics RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Starna Therapeutics Business Overview
Table 78. Starna Therapeutics SWOT Analysis
Table 79. Starna Therapeutics Recent Developments
Table 80. Hualan Biological Engineering Basic Information
Table 81. Hualan Biological Engineering RSV mRNA Vaccine Product Overview
Table 82. Hualan Biological Engineering RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Hualan Biological Engineering Business Overview
Table 84. Hualan Biological Engineering Recent Developments
Table 85. SINOVAC Basic Information
Table 86. SINOVAC RSV mRNA Vaccine Product Overview
Table 87. SINOVAC RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. SINOVAC Business Overview
Table 89. SINOVAC Recent Developments
Table 90. Moderna Basic Information
Table 91. Moderna RSV mRNA Vaccine Product Overview
Table 92. Moderna RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Moderna Business Overview
Table 94. Moderna Recent Developments
Table 95. GSK Basic Information
Table 96. GSK RSV mRNA Vaccine Product Overview
Table 97. GSK RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GSK Business Overview
Table 99. GSK Recent Developments
Table 100. Pfizer Basic Information
Table 101. Pfizer RSV mRNA Vaccine Product Overview
Table 102. Pfizer RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Pfizer Business Overview
Table 104. Pfizer Recent Developments
Table 105. Sanofi Basic Information
Table 106. Sanofi RSV mRNA Vaccine Product Overview
Table 107. Sanofi RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sanofi Business Overview
Table 109. Sanofi Recent Developments
Table 110. Nanoribo Basic Information
Table 111. Nanoribo RSV mRNA Vaccine Product Overview
Table 112. Nanoribo RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Nanoribo Business Overview
Table 114. Nanoribo Recent Developments
Table 115. Immorna Basic Information
Table 116. Immorna RSV mRNA Vaccine Product Overview
Table 117. Immorna RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Immorna Business Overview
Table 119. Immorna Recent Developments
Table 120. AIM Vaccine Basic Information
Table 121. AIM Vaccine RSV mRNA Vaccine Product Overview
Table 122. AIM Vaccine RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. AIM Vaccine Business Overview
Table 124. AIM Vaccine Recent Developments
Table 125. Shijiazhuang Pharma Group Basic Information
Table 126. Shijiazhuang Pharma Group RSV mRNA Vaccine Product Overview
Table 127. Shijiazhuang Pharma Group RSV mRNA Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shijiazhuang Pharma Group Business Overview
Table 129. Shijiazhuang Pharma Group Recent Developments
Table 130. Global RSV mRNA Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global RSV mRNA Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific RSV mRNA Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific RSV mRNA Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa RSV mRNA Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa RSV mRNA Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global RSV mRNA Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global RSV mRNA Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global RSV mRNA Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global RSV mRNA Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global RSV mRNA Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of RSV mRNA Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RSV mRNA Vaccine Market Size (M USD), 2025-2035
Figure 5. Global RSV mRNA Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global RSV mRNA Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RSV mRNA Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global RSV mRNA Vaccine Product Life Cycle
Figure 13. RSV mRNA Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global RSV mRNA Vaccine Revenue Share by Manufacturers in 2025
Figure 15. RSV mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market RSV mRNA Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by RSV mRNA Vaccine Revenue in 2025
Figure 18. Industry Chain Map of RSV mRNA Vaccine
Figure 19. Global RSV mRNA Vaccine Market PEST Analysis
Figure 20. Global RSV mRNA Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global RSV mRNA Vaccine Market Share by Type
Figure 27. Sales Market Share of RSV mRNA Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of RSV mRNA Vaccine by Type in 2025
Figure 29. Market Share of RSV mRNA Vaccine by Type (2020-2025)
Figure 30. Market Share of RSV mRNA Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global RSV mRNA Vaccine Market Share by Application
Figure 33. Global RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global RSV mRNA Vaccine Sales Market Share by Application in 2025
Figure 35. Global RSV mRNA Vaccine Market Share by Application (2020-2025)
Figure 36. Global RSV mRNA Vaccine Market Share by Application in 2025
Figure 37. Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global RSV mRNA Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global RSV mRNA Vaccine Market Size by Region (2020-2025)
Figure 40. North America RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America RSV mRNA Vaccine Sales Market Share by Country in 2024
Figure 43. North America RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America RSV mRNA Vaccine Market Size by Country in 2024
Figure 45. U.S. RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada RSV mRNA Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada RSV mRNA Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico RSV mRNA Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico RSV mRNA Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe RSV mRNA Vaccine Sales Market Share by Country in 2024
Figure 53. Europe RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe RSV mRNA Vaccine Market Size by Country in 2024
Figure 55. Germany RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific RSV mRNA Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific RSV mRNA Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific RSV mRNA Vaccine Market Size by Region in 2024
Figure 68. China RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America RSV mRNA Vaccine Sales and Growth Rate (K MT)
Figure 79. South America RSV mRNA Vaccine Sales Market Share by Country in 2024
Figure 80. South America RSV mRNA Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America RSV mRNA Vaccine Market Size by Country in 2024
Figure 82. Brazil RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa RSV mRNA Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa RSV mRNA Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa RSV mRNA Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa RSV mRNA Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global RSV mRNA Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global RSV mRNA Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global RSV mRNA Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global RSV mRNA Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global RSV mRNA Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global RSV mRNA Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global RSV mRNA Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of RSV mRNA Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RSV mRNA Vaccine Market Size (M USD), 2025-2035
Figure 5. Global RSV mRNA Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global RSV mRNA Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RSV mRNA Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global RSV mRNA Vaccine Product Life Cycle
Figure 13. RSV mRNA Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global RSV mRNA Vaccine Revenue Share by Manufacturers in 2025
Figure 15. RSV mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market RSV mRNA Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by RSV mRNA Vaccine Revenue in 2025
Figure 18. Industry Chain Map of RSV mRNA Vaccine
Figure 19. Global RSV mRNA Vaccine Market PEST Analysis
Figure 20. Global RSV mRNA Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global RSV mRNA Vaccine Market Share by Type
Figure 27. Sales Market Share of RSV mRNA Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of RSV mRNA Vaccine by Type in 2025
Figure 29. Market Share of RSV mRNA Vaccine by Type (2020-2025)
Figure 30. Market Share of RSV mRNA Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global RSV mRNA Vaccine Market Share by Application
Figure 33. Global RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global RSV mRNA Vaccine Sales Market Share by Application in 2025
Figure 35. Global RSV mRNA Vaccine Market Share by Application (2020-2025)
Figure 36. Global RSV mRNA Vaccine Market Share by Application in 2025
Figure 37. Global RSV mRNA Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global RSV mRNA Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global RSV mRNA Vaccine Market Size by Region (2020-2025)
Figure 40. North America RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America RSV mRNA Vaccine Sales Market Share by Country in 2024
Figure 43. North America RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America RSV mRNA Vaccine Market Size by Country in 2024
Figure 45. U.S. RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada RSV mRNA Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada RSV mRNA Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico RSV mRNA Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico RSV mRNA Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe RSV mRNA Vaccine Sales Market Share by Country in 2024
Figure 53. Europe RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe RSV mRNA Vaccine Market Size by Country in 2024
Figure 55. Germany RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific RSV mRNA Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific RSV mRNA Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific RSV mRNA Vaccine Market Size by Region in 2024
Figure 68. China RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America RSV mRNA Vaccine Sales and Growth Rate (K MT)
Figure 79. South America RSV mRNA Vaccine Sales Market Share by Country in 2024
Figure 80. South America RSV mRNA Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America RSV mRNA Vaccine Market Size by Country in 2024
Figure 82. Brazil RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa RSV mRNA Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa RSV mRNA Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa RSV mRNA Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa RSV mRNA Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa RSV mRNA Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa RSV mRNA Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global RSV mRNA Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China RSV mRNA Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global RSV mRNA Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global RSV mRNA Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global RSV mRNA Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global RSV mRNA Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global RSV mRNA Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global RSV mRNA Vaccine Market Share Forecast by Application (2026-2035)
